{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:51:03Z","timestamp":1774389063162,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2019J01508"],"award-info":[{"award-number":["2019J01508"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.pedneo.2021.06.018","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:46:59Z","timestamp":1630583219000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis"],"prefix":"10.1016","volume":"63","author":[{"given":"Jianwen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiguang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3383-5640","authenticated-orcid":false,"given":"Daohua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2021.06.018_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jprot.2014.10.012","article-title":"Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain","volume":"113","author":"Ramos","year":"2015","journal-title":"J Proteomics"},{"key":"10.1016\/j.pedneo.2021.06.018_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00228-015-1952-6","article-title":"Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens","volume":"72","author":"Lin","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/FTD.0000000000000456","article-title":"DosOpt: a tool for personalized Bayesian dose adjustment of vancomycin in neonates","volume":"39","author":"Tasa","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pedneo.2021.06.018_bib4","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/phar.1320","article-title":"Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis","volume":"33","author":"Stockmann","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pedneo.2021.06.018_bib5","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/AAC.04132-14","article-title":"Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients","volume":"59","author":"Glatard","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2021.06.018_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0924-8579(02)00188-7","article-title":"TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients","volume":"20","author":"Pea","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pedneo.2021.06.018_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2165\/00003088-199732040-00003","article-title":"Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective","volume":"32","author":"Samara","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pedneo.2021.06.018_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00003088-198611050-00004","article-title":"Population pharmacokinetics. Theory and clinical application","volume":"11","author":"Whiting","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pedneo.2021.06.018_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1078155215591386","article-title":"Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients","volume":"22","author":"Abdel Hadi","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.pedneo.2021.06.018_bib10","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1097\/PCC.0000000000001198","article-title":"A population pharmacokinetic analysis to study the effect of therapeutic hypothermia on vancomycin disposition in children resuscitated from cardiac arrest","volume":"18","author":"Zane","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.pedneo.2021.06.018_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/dkv372","article-title":"Pharmacokinetics of vancomycin and dosing recommendations for trauma patients","volume":"71","author":"Medell\u00edn-Garibay","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pedneo.2021.06.018_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1020254823597","article-title":"Assessment of type I error rates for the statistical sub-model in NONMEM","volume":"29","author":"W\u00e4hlby","year":"2002","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.pedneo.2021.06.018_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1011527125570","article-title":"Assessment of actual significance levels for covariate effects in NONMEM","volume":"28","author":"W\u00e4hlby","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.pedneo.2021.06.018_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.pedneo.2021.06.018_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PCC.0000000000001250","article-title":"Population pharmacokinetics and pharmacodynamic target attainment of vancomycin in neonates on extracorporeal life support","volume":"18","author":"Cies","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.pedneo.2021.06.018_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","article-title":"Stability and performance of a population pharmacokinetic model","volume":"37","author":"Ette","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.pedneo.2021.06.018_bib19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s11095-006-9067-5","article-title":"Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide","volume":"23","author":"Brendel","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.pedneo.2021.06.018_bib20","doi-asserted-by":"crossref","first-page":"105211","DOI":"10.18632\/oncotarget.22114","article-title":"A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pedneo.2021.06.018_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2710.2010.01215.x","article-title":"Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy","volume":"36","author":"Bondareva","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.pedneo.2021.06.018_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/FTD.0b013e31820f40f8","article-title":"Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation","volume":"33","author":"van der Meer","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pedneo.2021.06.018_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.34.5.792","article-title":"Vancomycin pharmacokinetics in burn patients and intravenous drug abusers","volume":"34","author":"Rybak","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2021.06.018_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/INF.0000000000000664","article-title":"Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients","volume":"34","author":"Ringenberg","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pedneo.2021.06.018_bib25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pedneo.2021.06.018_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/17512433.2015.1060124","article-title":"How to use vancomycin optimally in neonates: remaining questions","volume":"8","author":"Jacqz-Aigrain","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/pan.12176","article-title":"Neonatal clinical pharmacology","volume":"24","author":"Allegaert","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.pedneo.2021.06.018_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2431-14-193","article-title":"Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations","volume":"14","author":"Sinkeler","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.pedneo.2021.06.018_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/archdischild-2013-305309","article-title":"Therapeutic drug monitoring in neonates","volume":"101","author":"Pauwels","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2021.06.018_bib30","doi-asserted-by":"crossref","first-page":"F365","DOI":"10.1136\/adc.2010.196402","article-title":"Vancomycin prescription in neonates and young infants: toward a simplified dosage","volume":"96","author":"Oudin","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pedneo.2021.06.018_bib31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.6061\/clinics\/2012(07)21","article-title":"Clinical pharmacokinetics of vancomycin in the neonate: a review","volume":"67","author":"Pacifici","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.pedneo.2021.06.018_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2125.2010.03736.x","article-title":"Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline","volume":"70","author":"Marqu\u00e9s-Mi\u00f1ana","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib33","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1038\/s41598-021-85529-3","article-title":"Population pharmacokinetics and dose optimization of vancomycin in neonates","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.pedneo.2021.06.018_bib34","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/phar.2473","article-title":"Population pharmacokinetic study of vancomycin in Chinese pediatric patients with hematological malignancies","volume":"40","author":"Wang","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pedneo.2021.06.018_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fphar.2018.00603","article-title":"Population pharmacokinetics of vancomycin in Chinese ICU neonates: initial dosage recommendations","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00228-019-02664-7","article-title":"Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy","volume":"75","author":"Moffett","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/FTD.0000000000000490","article-title":"Hospitalized patients with and without hemodialysis have markedly different vancomycin pharmacokinetic: a population pharmacokinetic model-based analysis","volume":"40","author":"Goti","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pedneo.2021.06.018_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2125.2004.02143.x","article-title":"Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration","volume":"58","author":"DelDot","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib39","first-page":"722","article-title":"Clinical features and course of bacterial meningitis in children","volume":"116","author":"Juganariu","year":"2012","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.pedneo.2021.06.018_bib40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00228-018-2454-0","article-title":"Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants","volume":"74","author":"Chen","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2021.06.018_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.25.4.433","article-title":"Pharmacokinetics of vancomycin in patients with various degrees of renal function","volume":"25","author":"Matzke","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2021.06.018_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00007691-200010000-00004","article-title":"Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients","volume":"22","author":"Wrishko","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pedneo.2021.06.018_bib43","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1128\/AAC.48.4.1159-1167.2004","article-title":"Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates","volume":"48","author":"Kimura","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2021.06.018_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/AAC.44.2.278-282.2000","article-title":"A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population","volume":"44","author":"Lamarre","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:55:53Z","timestamp":1761749753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957221001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1875957221001662"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.06.018","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}